As-needed Combined Asthma Treatment Yields Better Symptom Control

As-needed Combined Asthma Treatment Yields Better Symptom Control

The Global Initiative for Asthma (GINA) recommends as-needed inhaled corticosteroid (ICS)-formoterol as an alternative to maintenance ICS plus short-acting β2-agonist (SABA) reliever at step 2 of its stepwise treatment algorithm. As-needed ICS-formoterol may be the preferred option when prevention of severe exacerbation is the primary aim of treatment.

Modern Medicine – Issue 6 2021